Pharma & Healthcare

Global Nano-antibody CDMO Services Market Research Report 2025

The global market for Nano-antibody CDMO Services was valued at US$ 468 million in the year 2024 and is projected to reach a revised size of US$ 1481 million by 2031, growing at a CAGR of 17.9% during the forecast period.
Nano-antibody CDMO service provides biopharmaceutical companies with full-process outsourcing support for nano-antibody drugs from research and development to commercialization, covering modules such as antibody screening, humanization, expression optimization, process development, GMP pilot production, formulation development and clinical application support. Compared with traditional IgG antibodies, nano-antibodies have the advantages of small size, strong penetration, easy modification, and high expression efficiency. They are widely used in tumor immunity, inflammation, autoimmunity, imaging diagnosis and inhalation preparations. With the rapid growth of the global nano-antibody drug pipeline, CDMO service platforms that focus on this type of molecule continue to develop and become an important sub-track in antibody CDMO, with high added value and high technical barriers.
North American market for Nano-antibody CDMO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nano-antibody CDMO Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Nano-antibody CDMO Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Nano-antibody CDMO Services include ProBio, GenScript, Sanofi, Abzena, Pierre Fabre, ImmunoPrecise Antibodies, PeptiFinder Biotech, Jotbody, 53Biologics, Shilpa Biologicals Private, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nano-antibody CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nano-antibody CDMO Services.
The Nano-antibody CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nano-antibody CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nano-antibody CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProBio
GenScript
Sanofi
Abzena
Pierre Fabre
ImmunoPrecise Antibodies
PeptiFinder Biotech
Jotbody
53Biologics
Shilpa Biologicals Private
Cultiply
PolyPeptide
CordenPharma
Bachem
Yaohai Bio
Nuoanjian Biotech
BioInno Biotechnology
Bioworkshops
Abace Biotechnology
Medicilon
Segment by Type
Antigen Design
Gene Synthesis
Vector Construction
Others
Segment by Application
Pharmaceutical Companies
Biological Laboratories
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano-antibody CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano-antibody CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antigen Design
1.2.3 Gene Synthesis
1.2.4 Vector Construction
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nano-antibody CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biological Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nano-antibody CDMO Services Market Perspective (2020-2031)
2.2 Global Nano-antibody CDMO Services Growth Trends by Region
2.2.1 Global Nano-antibody CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nano-antibody CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Nano-antibody CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Nano-antibody CDMO Services Market Dynamics
2.3.1 Nano-antibody CDMO Services Industry Trends
2.3.2 Nano-antibody CDMO Services Market Drivers
2.3.3 Nano-antibody CDMO Services Market Challenges
2.3.4 Nano-antibody CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano-antibody CDMO Services Players by Revenue
3.1.1 Global Top Nano-antibody CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Nano-antibody CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Nano-antibody CDMO Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nano-antibody CDMO Services Revenue
3.4 Global Nano-antibody CDMO Services Market Concentration Ratio
3.4.1 Global Nano-antibody CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano-antibody CDMO Services Revenue in 2024
3.5 Global Key Players of Nano-antibody CDMO Services Head office and Area Served
3.6 Global Key Players of Nano-antibody CDMO Services, Product and Application
3.7 Global Key Players of Nano-antibody CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano-antibody CDMO Services Breakdown Data by Type
4.1 Global Nano-antibody CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Nano-antibody CDMO Services Forecasted Market Size by Type (2026-2031)
5 Nano-antibody CDMO Services Breakdown Data by Application
5.1 Global Nano-antibody CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Nano-antibody CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nano-antibody CDMO Services Market Size (2020-2031)
6.2 North America Nano-antibody CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nano-antibody CDMO Services Market Size by Country (2020-2025)
6.4 North America Nano-antibody CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nano-antibody CDMO Services Market Size (2020-2031)
7.2 Europe Nano-antibody CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nano-antibody CDMO Services Market Size by Country (2020-2025)
7.4 Europe Nano-antibody CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Nano-antibody CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Nano-antibody CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nano-antibody CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Nano-antibody CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Nano-antibody CDMO Services Market Size (2020-2031)
9.2 Latin America Nano-antibody CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nano-antibody CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Nano-antibody CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano-antibody CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Nano-antibody CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nano-antibody CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Nano-antibody CDMO Services Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProBio
11.1.1 ProBio Company Details
11.1.2 ProBio Business Overview
11.1.3 ProBio Nano-antibody CDMO Services Introduction
11.1.4 ProBio Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.1.5 ProBio Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Nano-antibody CDMO Services Introduction
11.2.4 GenScript Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.2.5 GenScript Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Nano-antibody CDMO Services Introduction
11.3.4 Sanofi Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Abzena
11.4.1 Abzena Company Details
11.4.2 Abzena Business Overview
11.4.3 Abzena Nano-antibody CDMO Services Introduction
11.4.4 Abzena Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.4.5 Abzena Recent Development
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Details
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Nano-antibody CDMO Services Introduction
11.5.4 Pierre Fabre Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.5.5 Pierre Fabre Recent Development
11.6 ImmunoPrecise Antibodies
11.6.1 ImmunoPrecise Antibodies Company Details
11.6.2 ImmunoPrecise Antibodies Business Overview
11.6.3 ImmunoPrecise Antibodies Nano-antibody CDMO Services Introduction
11.6.4 ImmunoPrecise Antibodies Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.6.5 ImmunoPrecise Antibodies Recent Development
11.7 PeptiFinder Biotech
11.7.1 PeptiFinder Biotech Company Details
11.7.2 PeptiFinder Biotech Business Overview
11.7.3 PeptiFinder Biotech Nano-antibody CDMO Services Introduction
11.7.4 PeptiFinder Biotech Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.7.5 PeptiFinder Biotech Recent Development
11.8 Jotbody
11.8.1 Jotbody Company Details
11.8.2 Jotbody Business Overview
11.8.3 Jotbody Nano-antibody CDMO Services Introduction
11.8.4 Jotbody Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.8.5 Jotbody Recent Development
11.9 53Biologics
11.9.1 53Biologics Company Details
11.9.2 53Biologics Business Overview
11.9.3 53Biologics Nano-antibody CDMO Services Introduction
11.9.4 53Biologics Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.9.5 53Biologics Recent Development
11.10 Shilpa Biologicals Private
11.10.1 Shilpa Biologicals Private Company Details
11.10.2 Shilpa Biologicals Private Business Overview
11.10.3 Shilpa Biologicals Private Nano-antibody CDMO Services Introduction
11.10.4 Shilpa Biologicals Private Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.10.5 Shilpa Biologicals Private Recent Development
11.11 Cultiply
11.11.1 Cultiply Company Details
11.11.2 Cultiply Business Overview
11.11.3 Cultiply Nano-antibody CDMO Services Introduction
11.11.4 Cultiply Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.11.5 Cultiply Recent Development
11.12 PolyPeptide
11.12.1 PolyPeptide Company Details
11.12.2 PolyPeptide Business Overview
11.12.3 PolyPeptide Nano-antibody CDMO Services Introduction
11.12.4 PolyPeptide Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.12.5 PolyPeptide Recent Development
11.13 CordenPharma
11.13.1 CordenPharma Company Details
11.13.2 CordenPharma Business Overview
11.13.3 CordenPharma Nano-antibody CDMO Services Introduction
11.13.4 CordenPharma Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.13.5 CordenPharma Recent Development
11.14 Bachem
11.14.1 Bachem Company Details
11.14.2 Bachem Business Overview
11.14.3 Bachem Nano-antibody CDMO Services Introduction
11.14.4 Bachem Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.14.5 Bachem Recent Development
11.15 Yaohai Bio
11.15.1 Yaohai Bio Company Details
11.15.2 Yaohai Bio Business Overview
11.15.3 Yaohai Bio Nano-antibody CDMO Services Introduction
11.15.4 Yaohai Bio Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.15.5 Yaohai Bio Recent Development
11.16 Nuoanjian Biotech
11.16.1 Nuoanjian Biotech Company Details
11.16.2 Nuoanjian Biotech Business Overview
11.16.3 Nuoanjian Biotech Nano-antibody CDMO Services Introduction
11.16.4 Nuoanjian Biotech Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.16.5 Nuoanjian Biotech Recent Development
11.17 BioInno Biotechnology
11.17.1 BioInno Biotechnology Company Details
11.17.2 BioInno Biotechnology Business Overview
11.17.3 BioInno Biotechnology Nano-antibody CDMO Services Introduction
11.17.4 BioInno Biotechnology Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.17.5 BioInno Biotechnology Recent Development
11.18 Bioworkshops
11.18.1 Bioworkshops Company Details
11.18.2 Bioworkshops Business Overview
11.18.3 Bioworkshops Nano-antibody CDMO Services Introduction
11.18.4 Bioworkshops Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.18.5 Bioworkshops Recent Development
11.19 Abace Biotechnology
11.19.1 Abace Biotechnology Company Details
11.19.2 Abace Biotechnology Business Overview
11.19.3 Abace Biotechnology Nano-antibody CDMO Services Introduction
11.19.4 Abace Biotechnology Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.19.5 Abace Biotechnology Recent Development
11.20 Medicilon
11.20.1 Medicilon Company Details
11.20.2 Medicilon Business Overview
11.20.3 Medicilon Nano-antibody CDMO Services Introduction
11.20.4 Medicilon Revenue in Nano-antibody CDMO Services Business (2020-2025)
11.20.5 Medicilon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nano-antibody CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antigen Design
Table 3. Key Players of Gene Synthesis
Table 4. Key Players of Vector Construction
Table 5. Key Players of Others
Table 6. Global Nano-antibody CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nano-antibody CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nano-antibody CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nano-antibody CDMO Services Market Share by Region (2020-2025)
Table 10. Global Nano-antibody CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nano-antibody CDMO Services Market Share by Region (2026-2031)
Table 12. Nano-antibody CDMO Services Market Trends
Table 13. Nano-antibody CDMO Services Market Drivers
Table 14. Nano-antibody CDMO Services Market Challenges
Table 15. Nano-antibody CDMO Services Market Restraints
Table 16. Global Nano-antibody CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nano-antibody CDMO Services Market Share by Players (2020-2025)
Table 18. Global Top Nano-antibody CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-antibody CDMO Services as of 2024)
Table 19. Ranking of Global Top Nano-antibody CDMO Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nano-antibody CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nano-antibody CDMO Services, Headquarters and Area Served
Table 22. Global Key Players of Nano-antibody CDMO Services, Product and Application
Table 23. Global Key Players of Nano-antibody CDMO Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nano-antibody CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nano-antibody CDMO Services Revenue Market Share by Type (2020-2025)
Table 27. Global Nano-antibody CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nano-antibody CDMO Services Revenue Market Share by Type (2026-2031)
Table 29. Global Nano-antibody CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nano-antibody CDMO Services Revenue Market Share by Application (2020-2025)
Table 31. Global Nano-antibody CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nano-antibody CDMO Services Revenue Market Share by Application (2026-2031)
Table 33. North America Nano-antibody CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nano-antibody CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nano-antibody CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nano-antibody CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nano-antibody CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nano-antibody CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nano-antibody CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nano-antibody CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nano-antibody CDMO Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nano-antibody CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nano-antibody CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nano-antibody CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nano-antibody CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nano-antibody CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nano-antibody CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. ProBio Company Details
Table 49. ProBio Business Overview
Table 50. ProBio Nano-antibody CDMO Services Product
Table 51. ProBio Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 52. ProBio Recent Development
Table 53. GenScript Company Details
Table 54. GenScript Business Overview
Table 55. GenScript Nano-antibody CDMO Services Product
Table 56. GenScript Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 57. GenScript Recent Development
Table 58. Sanofi Company Details
Table 59. Sanofi Business Overview
Table 60. Sanofi Nano-antibody CDMO Services Product
Table 61. Sanofi Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 62. Sanofi Recent Development
Table 63. Abzena Company Details
Table 64. Abzena Business Overview
Table 65. Abzena Nano-antibody CDMO Services Product
Table 66. Abzena Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 67. Abzena Recent Development
Table 68. Pierre Fabre Company Details
Table 69. Pierre Fabre Business Overview
Table 70. Pierre Fabre Nano-antibody CDMO Services Product
Table 71. Pierre Fabre Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 72. Pierre Fabre Recent Development
Table 73. ImmunoPrecise Antibodies Company Details
Table 74. ImmunoPrecise Antibodies Business Overview
Table 75. ImmunoPrecise Antibodies Nano-antibody CDMO Services Product
Table 76. ImmunoPrecise Antibodies Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 77. ImmunoPrecise Antibodies Recent Development
Table 78. PeptiFinder Biotech Company Details
Table 79. PeptiFinder Biotech Business Overview
Table 80. PeptiFinder Biotech Nano-antibody CDMO Services Product
Table 81. PeptiFinder Biotech Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 82. PeptiFinder Biotech Recent Development
Table 83. Jotbody Company Details
Table 84. Jotbody Business Overview
Table 85. Jotbody Nano-antibody CDMO Services Product
Table 86. Jotbody Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 87. Jotbody Recent Development
Table 88. 53Biologics Company Details
Table 89. 53Biologics Business Overview
Table 90. 53Biologics Nano-antibody CDMO Services Product
Table 91. 53Biologics Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 92. 53Biologics Recent Development
Table 93. Shilpa Biologicals Private Company Details
Table 94. Shilpa Biologicals Private Business Overview
Table 95. Shilpa Biologicals Private Nano-antibody CDMO Services Product
Table 96. Shilpa Biologicals Private Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 97. Shilpa Biologicals Private Recent Development
Table 98. Cultiply Company Details
Table 99. Cultiply Business Overview
Table 100. Cultiply Nano-antibody CDMO Services Product
Table 101. Cultiply Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 102. Cultiply Recent Development
Table 103. PolyPeptide Company Details
Table 104. PolyPeptide Business Overview
Table 105. PolyPeptide Nano-antibody CDMO Services Product
Table 106. PolyPeptide Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 107. PolyPeptide Recent Development
Table 108. CordenPharma Company Details
Table 109. CordenPharma Business Overview
Table 110. CordenPharma Nano-antibody CDMO Services Product
Table 111. CordenPharma Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 112. CordenPharma Recent Development
Table 113. Bachem Company Details
Table 114. Bachem Business Overview
Table 115. Bachem Nano-antibody CDMO Services Product
Table 116. Bachem Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 117. Bachem Recent Development
Table 118. Yaohai Bio Company Details
Table 119. Yaohai Bio Business Overview
Table 120. Yaohai Bio Nano-antibody CDMO Services Product
Table 121. Yaohai Bio Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 122. Yaohai Bio Recent Development
Table 123. Nuoanjian Biotech Company Details
Table 124. Nuoanjian Biotech Business Overview
Table 125. Nuoanjian Biotech Nano-antibody CDMO Services Product
Table 126. Nuoanjian Biotech Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 127. Nuoanjian Biotech Recent Development
Table 128. BioInno Biotechnology Company Details
Table 129. BioInno Biotechnology Business Overview
Table 130. BioInno Biotechnology Nano-antibody CDMO Services Product
Table 131. BioInno Biotechnology Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 132. BioInno Biotechnology Recent Development
Table 133. Bioworkshops Company Details
Table 134. Bioworkshops Business Overview
Table 135. Bioworkshops Nano-antibody CDMO Services Product
Table 136. Bioworkshops Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 137. Bioworkshops Recent Development
Table 138. Abace Biotechnology Company Details
Table 139. Abace Biotechnology Business Overview
Table 140. Abace Biotechnology Nano-antibody CDMO Services Product
Table 141. Abace Biotechnology Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 142. Abace Biotechnology Recent Development
Table 143. Medicilon Company Details
Table 144. Medicilon Business Overview
Table 145. Medicilon Nano-antibody CDMO Services Product
Table 146. Medicilon Revenue in Nano-antibody CDMO Services Business (2020-2025) & (US$ Million)
Table 147. Medicilon Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report


List of Figures
Figure 1. Nano-antibody CDMO Services Picture
Figure 2. Global Nano-antibody CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nano-antibody CDMO Services Market Share by Type: 2024 VS 2031
Figure 4. Antigen Design Features
Figure 5. Gene Synthesis Features
Figure 6. Vector Construction Features
Figure 7. Others Features
Figure 8. Global Nano-antibody CDMO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nano-antibody CDMO Services Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Biological Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Nano-antibody CDMO Services Report Years Considered
Figure 14. Global Nano-antibody CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Nano-antibody CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Nano-antibody CDMO Services Market Share by Region: 2024 VS 2031
Figure 17. Global Nano-antibody CDMO Services Market Share by Players in 2024
Figure 18. Global Nano-antibody CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Nano-antibody CDMO Services Revenue in 2024
Figure 20. North America Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Nano-antibody CDMO Services Market Share by Country (2020-2031)
Figure 22. United States Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nano-antibody CDMO Services Market Share by Country (2020-2031)
Figure 26. Germany Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nano-antibody CDMO Services Market Share by Region (2020-2031)
Figure 34. China Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nano-antibody CDMO Services Market Share by Country (2020-2031)
Figure 42. Mexico Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nano-antibody CDMO Services Market Share by Country (2020-2031)
Figure 46. Israel Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Nano-antibody CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. ProBio Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 50. GenScript Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 52. Abzena Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 53. Pierre Fabre Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 54. ImmunoPrecise Antibodies Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 55. PeptiFinder Biotech Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 56. Jotbody Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 57. 53Biologics Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 58. Shilpa Biologicals Private Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 59. Cultiply Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 60. PolyPeptide Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 61. CordenPharma Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 62. Bachem Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 63. Yaohai Bio Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 64. Nuoanjian Biotech Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 65. BioInno Biotechnology Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 66. Bioworkshops Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 67. Abace Biotechnology Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 68. Medicilon Revenue Growth Rate in Nano-antibody CDMO Services Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies